Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson’s disease and Alzheimer’s disease but can be more difficult to diagnose.
FDA hits Neumora with clinical hold for schizophrenia drug after preclinical data showed convulsions in rabbits
Neumora Therapeutics has hit a road block to becoming a major neuroscience player, with the FDA placing a clinical hold on a Phase 1 study
April 16, 2024